Form 4: CME Group CEO Sells 25,000 Shares Under 10b5-1 Plan

CME Group Chairman and CEO Terrence A. Duffy sold 25,000 shares of Class A common stock for approximately $6.73 million through a pre-arranged trading plan.

Summary

• Terrence A. Duffy, Chairman and CEO of CME Group Inc. (CME), reported the sale of 25,000 shares of the company's Class A common stock.
• The transactions occurred on December 11, 2025, and were executed under a Rule 10b5-1 pre-arranged trading plan.
• The sales were conducted in two separate blocks: 13,089 shares at a weighted average price of $269.1 per share and 11,911 shares at a weighted average price of $270.05 per share.
• The total value of the shares sold is approximately $6,730,000.
• Following these transactions, Mr. Duffy's direct beneficial ownership of CME Group Class A common stock stands at 65,804 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While it's an insider sale, the execution under a pre-arranged 10b5-1 plan mitigates the negative implications, suggesting a planned financial move rather than a reaction to new, adverse company information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on new, non-public information, which can mitigate concerns about insider selling.

Negatives

• The Chairman and CEO reduced his direct beneficial ownership in the company by 25,000 shares, which could be perceived negatively by some investors.

Risks

• Insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a lack of confidence, potentially leading to negative sentiment or downward pressure on the stock price.

Future Outlook

NA

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. CME Group operates in the financial derivatives and exchange industry.

Stakeholder Impact

• Shareholders: May interpret the sale as a signal, though the 10b5-1 plan suggests it's not based on new information. Could lead to minor shifts in investor sentiment.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

CME Group, Terrence A. Duffy, Insider Sale, Form 4, 10b5-1 Plan, Common Stock, CEO, Director, Equity Transaction